well
establish
format
reactiv
metabolit
drug
associ
drug
toxic
similarli
accumul
data
suggest
role
format
reactiv
metabolitesintermedi
bioactiv
herbal
toxic
carcinogen
hypothes
result
reactiv
metabolit
follow
herbal
bioactiv
coval
bind
cellular
protein
dna
lead
toxic
via
multipl
mechan
direct
cytotox
oncogen
activ
hypersensit
reaction
exemplifi
aristoloch
acid
present
aristolochia
spp
undergo
reduct
nitro
group
hepat
cytochrom
peroxidas
extrahepat
tissu
reactiv
cyclic
nitrenium
ion
latter
capabl
react
dna
protein
result
activ
hra
oncogen
gene
mutat
final
carcinogenesi
exampl
pulegon
present
essenti
oil
mani
mint
speci
teucrin
diterpenoid
found
germand
teuchrium
chamaedri
use
adjuv
slim
diet
extens
pulegon
metabol
gener
pcresol
glutathion
depletori
furan
ring
diterpenoid
germand
oxid
reactiv
epoxid
react
protein
epoxid
hydrolas
hand
herbaldietari
constitu
shown
form
reactiv
intermedi
capabl
irrevers
inhibit
variou
cyp
result
metabolit
lead
cyp
inactiv
chemic
modif
heme
apoprotein
result
coval
bind
modifi
heme
apoprotein
exampl
includ
bergamottin
furanocoumarin
grapefruit
juic
capsaicin
chili
pepper
glabridin
isoflavan
licoric
root
isothiocyan
found
crucifer
veget
oleuropein
rich
oliv
oil
dialli
sulfon
found
garlic
resveratrol
constitu
red
wine
cyp
known
metabol
therapeut
drug
activ
number
procarcinogen
well
therefor
see
front
matter
sg
zhou
wwwelseviercomlocatelifesci
life
scienc
mechanismbas
inhibit
cyp
may
provid
explan
report
herbdrug
interact
chemoprevent
activ
herb
due
wide
use
easi
avail
herbal
medicin
increas
concern
herbal
toxic
safeti
qualiti
herbal
medicin
ensur
greater
research
pharmacovigil
greater
regulatori
control
better
commun
patient
health
profession
metabol
reactiv
intermedi
inactiv
enzym
classifi
mechanismbas
inhibitor
thu
inhibit
cypmedi
carcinogen
activ
herbaldietari
constitu
extens
studi
mechan
herbal
toxic
remain
elus
accumul
data
suggest
role
format
reactiv
metabolitesintermedi
bioactiv
major
herbal
constitu
herbal
toxic
carcinogen
hypothes
result
reactiv
metabolit
follow
herbal
bioactiv
coval
bind
cellular
protein
dna
lead
toxic
via
multipl
mechan
direct
cytotox
oncogen
activ
hypersensit
reaction
review
highlight
role
format
reactiv
intermedi
via
bioactiv
herbal
toxic
use
aristoloch
acid
pulegon
germand
exampl
addit
mechanismbas
inhibit
cyp
mani
herbal
constitu
clinic
toxicolog
relev
discuss
aristoloch
acid
aa
famili
structur
relat
nitrophenanthren
carboxyl
acid
primarili
herbal
medicin
aristolochia
spp
eg
fangchi
guang
fangji
clematit
manshuriensi
ioset
et
al
predomin
aa
aai
acid
aaii
acid
consumpt
herb
contain
aa
associ
sever
nephropathi
character
uniqu
renal
fibrosi
develop
urotheli
cancer
abt
et
al
arlt
et
al
cosyn
lord
et
al
nortier
vanherweghem
schwetz
zhu
approxim
case
aa
nephropathi
report
worldwid
mani
need
renal
replac
therapi
arlt
et
al
larg
cohort
patient
aa
nephropathi
develop
urotheli
cancer
cosyn
nortier
vanherweghem
alkaloid
aai
aaii
underw
reduct
nitro
group
catalyz
oxid
enzym
reactiv
cyclic
nitrenium
ion
fig
schmeiser
et
al
stiborova
et
al
b
stiborova
et
al
hepat
microsom
nadph
cyp
reductas
dtdiaphoras
peroxidas
found
catalyz
reaction
addit
inhibitor
induc
found
decreas
increas
format
dna
adduct
stiborova
et
al
b
result
reactiv
cyclic
nitrenium
ion
capabl
react
dna
andor
protein
lead
adduct
format
exampl
dna
adduct
eg
deoxyadenosinn
aristolactam
ii
deoxyguanosinn
yl
aristolactam
ii
detect
kidney
uret
tissu
patient
take
herb
contain
aa
sever
month
even
year
cessat
herbal
consumpt
schmeiser
et
al
stiborova
et
al
former
predomin
dna
adduct
human
rat
tissu
schmeiser
et
al
stiborova
et
al
studi
mous
rat
indic
hra
protooncogen
activ
high
incid
ta
transvers
mutat
codon
dna
aaiinduc
tumor
schmeiser
et
al
consist
identif
adduct
form
vitro
patient
result
indic
deoxyadenosin
adduct
format
critic
step
tumor
initi
aa
recent
studi
use
elacz
transgen
mice
shown
administr
aa
caus
select
ta
mutat
kohara
et
al
agreement
extens
deoxyadenosinn
yl
aristolactam
adduct
format
rat
human
rat
treat
singl
dose
aai
deoxyguanosinn
yl
aristolactam
adduct
remov
continu
dna
wherea
deoxyadenosinn
yl
aristolactam
adduct
persist
without
proper
repair
dna
fernando
et
al
lead
mutat
oncogen
activ
pulegon
monoterpen
keton
present
essenti
oil
mani
mint
speci
eg
hedeoma
pulegoid
mentha
pulegium
call
pennyroy
budavari
grundschob
pennyroy
oil
use
flavor
agent
food
beverag
fragrant
constitu
flea
repel
hall
oser
pennyroy
also
use
induc
menstruat
abort
howev
pennyroy
oil
especi
high
dose
report
caus
hepat
failur
central
nervou
system
toxic
gastriti
renal
pulmonari
toxic
death
anderson
et
al
pulegon
constitut
terpen
pennyroy
oil
found
hepatotox
pneumotox
mice
gordon
et
al
metabolit
pulegon
consid
respons
toxic
gordon
et
al
menthofuran
pcresol
potenti
candid
menthofuran
natur
occur
hepatotoxin
thomassen
et
al
pcresol
known
glutathion
depletori
toxin
thompson
et
al
vitro
studi
demonstr
cypmedi
convers
pulegon
menthofuran
bioactiv
reactiv
gketoen
gordon
et
al
thomassen
et
al
gketoen
capabl
coval
bind
cellular
protein
caus
hepat
injuri
thomassen
et
al
gketoen
convert
mintlacton
well
reactiv
intermedi
cypmedi
oxid
menthofuran
vivo
metabol
pulegon
complic
phase
phase
ii
metabolit
identifi
character
rat
chen
et
al
madyastha
raj
mcclanahan
et
al
moorthi
et
al
thomassen
et
al
metabolit
account
total
radioact
excret
bile
structur
could
establish
sole
mass
spectral
analysi
metabol
pulegon
rat
involv
three
major
metabol
pathway
conjug
glucuron
acid
follow
methyl
group
hydroxyl
gsh
conjug
metabol
b
format
menthofuran
c
format
piperitenon
begin
follow
dehydr
fig
chen
et
al
madyastha
gaikwad
madyastha
raj
madyastha
raj
cyp
system
play
import
role
metabol
r
pulegon
madyastha
gaikwad
madyastha
raj
metabolit
pulegon
deriv
menthofuran
piperitenon
madyastha
gaikwad
madyastha
raj
madyastha
raj
studi
carri
vivo
shown
one
metabolit
r
pulegon
madyastha
raj
convers
pcresol
demonstr
vitro
madyastha
raj
madyastha
raj
madyastha
raj
germand
teuchrium
chamaedri
diterpenoidcontain
herbal
medicin
tradit
use
folk
medicin
alleg
choleret
antisept
effect
germand
tea
capsul
promot
adjuv
slim
diet
howev
case
hepatotox
mainli
cytolyt
hepat
chronic
hepat
cirrhosi
consumpt
germand
report
mainli
franc
includ
case
posit
rechalleng
ben
yahia
et
al
castot
larrey
dao
et
al
lalibert
villeneuv
larrey
et
al
mattei
et
al
fatal
due
fulmin
hepat
necrosi
mostefakara
et
al
medicin
plant
prohibit
franc
sinc
germand
caus
hepatotox
anim
kouzi
et
al
loeper
et
al
human
lalibert
villeneuv
germand
contain
saponin
glycosid
flavonoid
furano
neoclerodan
diterpenoid
piozzi
et
al
hepatotox
ascrib
diterpenoid
includ
teucrin
teuchamaedryn
furan
ring
diterpenoid
oxid
reactiv
epoxid
react
protein
epoxid
hydrolas
fig
fau
et
al
lekeh
et
al
loeper
et
al
loeper
et
al
reactiv
epoxid
led
mitochondri
permeabl
transit
caspas
activ
apoptosi
rat
mous
hepatocyt
fau
et
al
lekeh
et
al
loeper
et
al
teucrin
coval
bound
rat
hepatocyt
protein
furano
diterpenoid
fraction
decreas
cell
gsh
cytoskeletonassoci
protein
thiol
increas
cytosol
level
ca
fau
et
al
lekeh
et
al
event
led
format
plasma
membran
bleb
dna
fragment
cell
apoptosi
diterpenoidmedi
cytotox
modul
mani
factor
induc
inhibitor
pretreat
male
rat
troleandomycin
inhibitor
reduc
cellular
gsh
deplet
cytotox
wherea
dexamethason
treatment
induc
opposit
effect
lekeh
et
al
feed
male
rat
sulfur
amino
aciddefici
diet
decreas
cellular
gsh
level
enhanc
cytotox
wherea
supplement
standard
diet
cystin
opposit
effect
lekeh
et
al
femal
rat
hepatocyt
exhibit
littl
toxic
express
low
level
unless
anim
treat
dexamethason
lekeh
et
al
furthermor
hepatotox
mice
attenu
pretreat
butyl
hydroxyanisol
clofibr
two
induc
microsom
epoxid
hydrolas
markedli
increas
phoroneinduc
gsh
deplet
loeper
et
al
pretreat
mice
either
phenobarbit
effect
loeper
et
al
addit
genet
factor
may
import
develop
germanderinduc
hepatotox
exampl
polymorph
major
histocomp
complex
molecul
affect
format
toxic
metabolit
antigen
present
helper
cell
respect
epoxid
hydrolas
plasma
membraneloc
phase
ii
microsom
enzym
catalyt
compet
may
particip
inactiv
reactiv
epoxid
aris
teucrin
thu
may
act
target
reactiv
metabolit
teucrin
incub
teucrin
epoxid
hydrolas
inactiv
timedepend
manner
suggest
reactiv
oxid
deriv
teucrin
could
alkyl
inactiv
enzym
de
berardini
et
al
interestingli
antimicrosom
epoxid
hydrolas
autoantibodi
detect
sera
patient
take
germand
tea
long
period
time
de
berardini
et
al
loeper
et
al
polymero
et
al
dosedepend
immunoprecipit
human
epoxid
hydrolas
human
sera
confirm
human
epoxid
hydrolas
autoantigen
target
de
berardini
et
al
appear
direct
toxic
secondari
immun
reaction
involv
germanderinduc
heaptotox
coval
bind
epoxid
hydrolas
outer
surfac
human
hepatocyt
teucrin
might
trigger
immun
respons
induc
format
autoantibodi
lead
cell
dealth
mani
herbal
constitu
found
inhibit
variou
cyp
natur
inhibit
may
competit
noncompetit
mechanismbas
latter
character
nadph
timeand
concentrationdepend
enzym
inactiv
occur
herbal
constitu
convert
cyp
reactiv
metabolit
capabl
irrevers
bind
cyp
ortiz
de
montellano
correia
osawa
pohl
silverman
mechanismbas
inhibitor
requir
least
one
cycl
cyp
catalyt
process
form
reactiv
metabolit
result
metabolit
lead
cyp
inactiv
chemic
modif
heme
apoprotein
result
coval
bind
modifi
heme
apoprotein
capsaicin
major
pungent
phenol
constitu
present
varieti
capsicum
fruit
hot
pepper
thu
repres
import
ingredi
major
spici
food
park
et
al
surh
lee
shown
wide
rang
pharmacolog
properti
includ
painkil
antigenotox
antimutagen
anticarcinogen
effect
surh
lee
capsaicin
use
treat
variou
peripher
pain
condit
rheumatoid
arthriti
diabet
neuropathi
surh
lee
howev
capsaicin
report
tumor
promot
carcinogen
potenti
mutagen
agarw
et
al
lopezcarillo
et
al
toth
gannett
ward
lopezcarrillo
caus
strand
scission
calf
thymu
plasmid
dna
presenc
cu
ii
breakag
mediat
reactiv
oxygen
speci
aris
capsaicin
especi
hydroxyl
radic
singh
et
al
b
capsaicin
undergo
bioactiv
reactiv
speci
gannett
et
al
major
bioactiv
pathway
includ
epoxid
vanillyl
ring
moieti
produc
aren
oxid
b
oneelectron
oxid
ring
hydroxyl
group
phenoxi
radic
c
odemethyl
aromat
ring
subsequ
oxid
result
catechol
metabolit
semiquinon
quinon
deriv
fig
result
reactiv
speci
capabl
bind
coval
activ
site
well
dna
surh
lee
interact
target
cell
dna
would
trigger
mutagen
malign
transform
howev
metabol
capsaicinoid
cyp
may
also
repres
detoxif
process
contrast
bioactiv
result
reduct
cytotox
reilli
et
al
exampl
novel
dehydrogen
metabol
pathway
capsaicin
yield
macrocycl
dien
imid
metabolit
reilli
et
al
bergamottin
major
furanocoumarin
grapefruit
juic
revers
inhibit
activ
human
liver
microsom
et
al
also
inactiv
follow
metabol
activ
timeand
concentrationdepend
manner
k
inact
k
valu
min
respect
et
al
loss
catalyt
activ
exhibit
pseudofirstord
kinet
bergamottininduc
inactiv
retain
heme
apoprotein
inactiv
could
recov
suggest
inactiv
may
involv
apoprotein
modif
activ
site
enzym
instead
heme
adduct
format
heme
fragment
et
al
reactiv
metabolit
bergamottin
remain
unknown
may
undergo
oxid
form
reactiv
furanoepoxid
coval
bind
fig
natur
furanocoumarin
rich
mani
foodstuff
parsnip
parsley
use
combin
long
wavelength
ultraviolet
light
treat
psoriasi
vitiligo
cell
lymphoma
anderson
voorhe
edelson
et
al
parrish
et
al
use
treat
diseas
resid
abil
photoactiv
speci
capabl
bind
coval
nucleic
acid
lymphocyt
thu
inhibit
dna
synthesi
cellular
prolifer
earli
studi
indic
potent
mechanismbas
inhibitor
cyp
rodent
fouinfortunet
et
al
labb
et
al
letteron
et
al
may
et
al
human
tinel
et
al
studi
found
potent
mechanismbas
inhibitor
k
k
inact
min
reconstitut
nativ
liver
microsom
koenig
et
al
koenig
trager
b
maenpaa
et
al
also
potent
inactiv
k
k
inact
min
koenig
trager
b
howev
reactiv
speci
remain
unknown
suggest
furanocoumarin
undergo
oxid
form
furanoepoxid
fig
result
epoxid
convert
dihydrofuranocoumarin
product
follow
hydrolyt
attack
direct
attack
exogen
nucleophil
koenig
trager
b
dri
root
licoric
glycyrrhiza
glabra
consum
past
year
use
flavor
sweat
agent
demulc
expector
western
world
antiallerg
antiinflammatori
agent
asian
countri
includ
japan
china
chandler
licoric
contain
glycyrrhizin
glycyrrhiz
acid
glycosid
time
sweeter
sugar
olean
triterpenoid
glucos
ammonia
polyphenol
flavonoid
sucros
hatano
et
al
b
flavanoid
compon
licoric
root
shown
antitumorigen
antimicrobi
antivir
antiinflammatori
estrogenlik
antioxid
activ
fujisawa
et
al
fukai
et
al
shibata
tamir
et
al
licoric
root
extract
well
major
flavanoid
isoflavan
glabridin
potent
antioxid
ldl
oxid
mice
human
rosenblat
et
al
glabridin
also
shown
inhibit
activ
macrophag
nadphoxidas
presum
inhibit
protein
kinas
c
serotonin
reuptak
ofir
et
al
rosenblat
et
al
addit
glycyrrhizin
recent
found
potent
inhibitor
sarsassoci
coronaviru
vitro
cinatl
et
al
howev
licoric
may
caus
hypermineralocorticoid
nobata
et
al
arrhythmia
bocker
breithardt
pseudoaldosteron
ferrari
et
al
hypertens
astrup
toxic
ascrib
inhibitori
activ
glycyrrhizin
glycyrrhet
acid
licoric
dehydrogenas
ferrari
et
al
vitro
studi
indic
glabridin
inactiv
timeand
concentrationdepend
manner
competit
inhibit
kent
et
al
metabol
glabridin
result
destruct
heme
moieti
loss
activ
differ
concentr
glabridin
correl
well
loss
carbon
oxid
spectrum
detect
heme
nm
kent
et
al
peak
indic
glabridinalkyl
heme
elut
nativ
heme
detect
nm
presum
glabridin
undergo
metabol
form
reactiv
intermedi
caus
heme
fragment
incub
lead
loss
enzymat
activ
incub
glabridin
nadph
result
metabolit
suggest
two
hydroxyl
group
flavonoid
b
ring
glabridin
requir
inactiv
fig
kent
et
al
inde
two
hydroxyl
group
also
believ
essenti
antioxid
activ
belinki
et
al
isothiocyan
releas
upon
chew
macer
crucifer
veget
cabbag
cauliflow
broccoli
occur
thioglucosid
conjug
call
glucosinol
fenwick
et
al
enzym
myrosinas
releas
time
hydrolyz
glucosinol
rearrang
intermedi
produc
isothiocyan
hydrogen
sulfat
glucos
major
product
typic
isothiocyan
includ
benzyl
isothiocyan
bitc
phenethyl
isothiocyan
peitc
compound
shown
potent
modul
cyp
vitro
vivo
isothiocyan
inhibit
involv
carcinogen
activ
yang
et
al
bitc
peitc
shown
inhibit
nnitrosodimethylamin
demethyl
activ
bitc
potent
mechanismbas
inactiv
rat
well
human
goosen
et
al
moreno
et
al
k
respect
correspond
k
inact
valu
min
respect
goosen
et
al
moreno
et
al
human
rat
inactiv
bitc
bitc
also
potent
inactiv
indic
partit
ratio
approxim
goosen
et
al
mechan
cyp
inhibit
isothiocyan
involv
competit
mechanimsbas
inhibit
competit
inhibit
involv
competit
substrat
activ
site
cyp
ishizaki
et
al
smith
et
al
mechanismbas
inhibit
would
involv
metabol
activ
isothiocyan
goosen
et
al
ishizaki
et
al
lee
moreno
et
al
smith
et
al
metabol
activ
isothiocyan
result
reactiv
intermedi
could
ultim
bind
heme
moieti
apoprotein
therebi
inactiv
enzym
exampl
bitc
metabol
reactiv
benzyl
isocyan
intermedi
capabl
bind
coval
cyp
apoprotein
hydrolyz
form
benzylamin
fig
goosen
et
al
bitc
may
oxid
acarbon
benzaldehyd
instead
desulfur
benzyl
isocyan
altern
benzylamin
could
deamin
give
benzaldehyd
ammonia
subsequ
oxid
benzaldehyd
would
yield
benzoic
acid
format
benzoic
acid
also
observ
dog
administr
bitc
result
excret
hippur
acid
glycin
conjug
benzoic
acid
et
al
human
rat
bitc
metabol
conjug
gsh
final
excret
mercaptur
acid
addit
oxid
desulfur
isothiocyan
could
also
releas
element
sulfur
could
contribut
enzymat
modif
possibl
inactiv
case
parathion
butler
murray
vivo
administr
isothiocyan
rodent
also
modul
cyp
content
activ
guo
et
al
smith
et
al
effect
appear
depend
experiment
condit
isothiocyan
use
treatment
regimen
target
tissu
specif
cyp
evalu
zhang
talalay
exampl
acut
administr
peitc
rat
decreas
liver
activ
wherea
activ
content
increas
approxim
without
signific
effect
lung
activ
guo
et
al
howev
chronic
administr
peitc
induc
relat
increas
carcinogenesi
smith
et
al
kava
piper
methysticum
found
polynesia
melanesia
micronesia
effect
herbal
medicin
therapi
anxieti
insomnia
pittler
ernst
rous
singh
singh
volz
kieser
clinic
studi
shown
kava
kavalacton
effect
treatment
anxieti
subclin
clinic
level
anxieti
associ
menopaus
variou
medic
condit
bilia
et
al
pittler
ernst
stevinson
et
al
volz
kieser
wheatley
major
constitu
kava
pharmacolog
activ
kavalacton
respons
total
activ
kava
singh
singh
yangonin
desmethoxyyangonin
methysticin
kawain
present
highest
level
kavalacton
account
approxim
lipid
extract
lebot
methysticin
dihydromethysticin
fig
mechanismbas
inhibitor
cyp
indic
unidentifi
metabol
intermedi
complex
nm
incub
human
liver
microsom
mathew
et
al
absorb
complex
nadphand
timedepend
absorpt
increas
increas
incub
time
methysticin
analog
kava
extract
shown
inhibit
multipl
cyp
metabol
activ
format
metabol
intermedi
complex
murray
reidi
murray
et
al
preincub
whole
kava
extract
human
liver
microsom
inhibit
wherea
unaffect
mathew
et
al
variou
kavalacton
inhibit
differ
cyp
kava
extract
kavalacton
inhibit
cdnaexpress
microsom
unger
et
al
mediterranean
diet
associ
longev
low
rate
coronari
arteri
diseas
cancer
despit
high
dietari
fat
content
braga
et
al
owen
et
al
roch
et
al
mediterranean
diet
includ
consumpt
larg
amount
oliv
oil
oliv
oil
sourc
least
phenol
compound
total
mgkg
tuck
haybal
benefici
effect
oliv
oil
mainli
attribut
oleuropein
two
major
metabolit
hydroxytyrosol
tyrosol
oleuropein
major
phenol
compound
oliv
fruit
much
dri
fruit
ester
consist
hydroxytyrosol
elenol
acid
potent
antioxid
agent
briant
et
al
phenol
compon
oliv
oil
believ
play
vital
role
prevent
coronari
arteri
diseas
atherosclerosi
compound
particular
hydroxytyrosol
potent
antioxid
radic
scaveng
tuck
haybal
visiol
galli
visioli
galli
visioli
et
al
exert
protect
effect
cardiovascular
system
mainli
inhibit
platelet
aggreg
endotheli
activ
carluccio
et
al
modul
arachidon
acid
metabol
kohyama
et
al
prevent
oxid
low
densiti
lipid
visiol
galli
visioli
et
al
visioli
et
al
presum
hydroxytyrosol
water
lipid
solubl
molecul
penetr
cell
membran
thu
inhibit
product
leukotrien
effect
endogen
arachidon
acid
kohyama
et
al
vitro
studi
indic
oleuropein
inactiv
androstenedion
activ
human
liver
microsom
k
inact
k
min
respect
stupan
et
al
stupan
et
al
reactiv
metabolit
oleuropein
remain
undetermin
oleuropein
might
undergo
oxid
unidentifi
metabolit
capabl
bind
inactiv
fig
addit
hydroxytyrosol
tyrosol
andor
metabolit
may
involv
metabol
studi
indic
hydroxytyosol
excret
urin
unchang
glucuronid
sulfat
conjug
fig
mirocasa
et
al
tsarbopoulo
et
al
tuck
haybal
hydroxytyrosol
also
sequenti
oxid
acid
alcohol
aldehyd
dehydrogenas
methyl
catechol
methyltransferas
homovanil
acid
oxid
homovanil
alcohol
dangelo
et
al
garlic
frequent
use
flavorenhanc
ingredi
food
prepar
healthi
supplement
practic
folk
medicin
organosulfur
compound
major
activ
compon
garlic
garlic
also
contain
numer
flavonoidsisoflavonoid
nobiletin
quercetin
rutin
tangeretin
polysaccharid
prostaglandin
saponin
terpen
citral
geraniol
linalool
aand
hphellandren
dausch
nixon
singh
et
al
b
alliin
sallylcystein
sulfoxid
one
major
compon
garlic
convert
alliinas
allicin
allicin
transform
garlic
compound
includ
diallyl
sulfid
organosulfur
compound
report
hypolipidem
antiplatelet
immuneenhanc
anticanc
chemoprevent
hepatoprotect
antihypertens
procirculatori
effect
rahman
spigelski
jone
organosulfar
compound
modul
cyp
vitro
vivo
bradi
et
al
exampl
extract
fresh
garlic
sampl
garlic
oil
freez
dri
garlic
age
garlic
inhibit
human
activ
wherea
activ
unalt
foster
et
al
organosulfur
compound
disulfid
dinpropyl
disulfid
diallyl
sulfid
also
potent
competit
inhibitor
coumarin
k
valu
respect
fujita
kamataki
vivo
studi
mous
indic
garlic
administr
increas
level
kishimoto
et
al
wherea
administr
garlic
constitu
rat
decreas
activ
andor
protein
level
increas
alter
activ
dalvi
haber
et
al
haber
et
al
singl
dose
garlic
oil
rat
result
signific
inhibit
hepat
cypcatalyz
reaction
includ
aminopyrin
ndemethylas
anilin
hydroxylas
activ
administr
garlic
day
led
signific
increas
hepat
cyp
activ
fitzsimmon
collin
addit
administr
garlic
oil
healthi
subject
day
reduc
activ
chlorzoxazon
use
probe
compound
gurley
et
al
diallyl
sulfid
convert
diallyl
sulfoxid
sequenti
diallyl
sulfon
fig
teyssier
et
al
compound
competit
inhibitor
bradi
et
al
singl
oral
dose
diallyl
sulfon
inactiv
activ
mous
liver
microsom
lin
et
al
diallyl
sulfon
also
mechanismbas
inhibitor
involv
format
reactiv
metabolit
form
cyp
complex
lead
autocatalyt
destruct
bradi
et
al
jin
bailli
premda
et
al
recent
studi
demonstr
diallyl
sulfon
oxid
one
termin
doubl
bond
yield
monoallyleopoxid
inactiv
fig
premda
et
al
monoallyleopoxid
conjug
gsh
appear
reactiv
intermedi
diallyl
sulfon
might
initi
affect
heme
andor
apoprotein
resveratrol
polyphenol
phytoalexin
found
red
wine
grape
peanut
report
antioxid
cardioprotect
antimutagen
antiinflammatori
chemoprevent
antiplatelet
effect
aziz
et
al
cal
et
al
gusman
et
al
kimura
orallo
et
al
roemer
mahyarroem
resveratrol
also
report
possess
substanti
cytotox
activ
differ
tumour
cell
line
elmowafi
alkhalaf
ferrydumazet
et
al
kuo
et
al
roman
et
al
cytotox
may
ascrib
suppress
activ
nfnb
cell
prolifer
inhibit
dna
synthesi
kuwajerwala
et
al
induct
arrest
apoptosi
tumour
cell
estrov
et
al
liang
et
al
nile
et
al
pozoguisado
et
al
roman
et
al
addit
resveratrol
abl
activ
estrogen
receptor
bhat
et
al
kling
et
al
levenson
et
al
mueller
et
al
ratna
simonelli
inhibit
eicosanoid
synthesi
johnson
maddipati
martinez
moreno
moreno
paceasciak
et
al
activ
adenylyl
guanylyl
cyclas
elmowafi
elmowafi
alkhalaf
enhanc
express
activ
endotheli
nitric
oxid
synthas
hattori
et
al
wallerath
et
al
resveratrol
shown
irrevers
mechanismbas
inhibitor
noncompetit
revers
inhibitor
ic
valu
microsom
rat
liver
human
liver
cell
contain
cdnaexpress
cyp
chan
delucchi
chan
et
al
piver
et
al
studi
use
insect
microsom
contain
baculovirusderiv
human
nadphcytochrom
cyp
reductas
resveratrol
inactiv
timeand
nadphdepend
manner
k
inact
k
min
respect
chan
fig
metabol
diallyl
sulfid
delucchi
chan
et
al
resveratrol
electronrich
molecul
two
aromat
benzen
ring
link
ethylen
bridg
aromat
hydroxyl
epoxid
compound
possibl
result
reactiv
pbenzoquinon
methid
metabolit
capabl
bind
coval
inactiv
fig
interestingli
qviniferin
dimer
resveratrol
mechanismbas
inhibitor
human
cyp
piver
et
al
show
mixedtyp
inhibit
variou
cyp
k
except
noncompetit
qviniferin
isol
wine
concentr
landrault
et
al
gener
oxid
resveratrol
parent
compound
produc
grapevin
respons
fungal
infect
qviniferin
shown
better
antifung
antioxid
activ
resveratrol
baderschneid
winterhalt
bala
et
al
qviniferin
also
hepatoprotect
activ
oshima
et
al
herb
often
administ
combin
therapeut
drug
rais
potenti
pharmacokinet
andor
pharmacodynam
herbdrug
interact
number
clinic
import
herbdrug
interact
document
mani
led
alter
efficaci
andor
advers
event
fughberman
fughberman
ernst
pharmacokinet
herbdrug
interact
due
alter
absorpt
metabol
distribut
excret
drug
frequent
one
underli
mechan
alter
drug
concentr
concomit
herbal
medicin
induct
inhibit
hepat
intestin
cyp
express
high
level
villu
tip
enterocyt
primari
site
absorpt
oral
administ
drug
thu
modul
intestin
repres
import
mechan
enhanc
reduc
bioavail
coadminist
drug
particular
mechanismbas
inhibit
cyp
particular
herbal
constitu
may
import
pharmacokinet
implic
administr
garlic
extract
month
healthi
volunt
alter
oxid
metabol
acetaminophen
caus
slight
increas
sulfat
gwilt
et
al
howev
studi
mice
indic
diallyl
sulfon
decreas
plasma
level
oxid
acetaminophen
metabolit
nonoxid
acetaminophen
metabolit
lin
et
al
consid
due
inhibit
major
enzym
respons
acetaminophen
bioactiv
manyik
et
al
liver
microsom
diallyl
sulfon
significantli
inhibit
acetaminophen
oxid
nacetylpbenzoquinon
imin
toxic
metabolit
acetamoniphen
lin
et
al
result
provid
explan
protect
effect
diallyl
sulfon
acetaminopheninduc
hepatotox
lin
et
al
administ
oral
hr
prior
immedi
min
toxic
dose
acetaminophen
diallyl
sulfon
mgkg
complet
protect
mice
develop
hepatotox
lin
et
al
case
report
pharmacolog
studi
indic
potenti
central
nervou
system
effect
benzodiazepin
includ
alprazolam
almeida
grimsley
presenc
kava
extract
andor
kavalacton
sinc
alprazolam
substrat
gorski
et
al
kavalacton
potent
inhibitor
zou
et
al
decreas
elimin
alprazolam
kava
may
contribut
addit
effect
report
upon
coadministr
kava
alprazolam
coadministr
kava
markedli
increas
hexobarbit
sleep
time
meyer
ethanolinduc
hypnot
effect
jamieson
duffield
mice
indic
inhibit
crossov
studi
healthi
human
volunt
oral
ingest
aqueou
licoric
extract
day
significantli
alter
pharmacokinet
paramet
sed
effect
midazolam
shon
et
al
midazolam
typic
substrat
gorski
et
al
discrep
vitro
anim
human
studi
may
reflect
import
herbal
dose
regimen
modul
cyp
grapefruit
juic
found
significantli
increas
oral
bioavail
dihydropyridin
eg
felodipin
terfenadin
saquinavir
cyclosporin
midazolam
triazolam
verapamil
bailey
et
al
bailey
et
al
ducharm
et
al
et
al
kane
lipski
mohri
uesawa
yee
et
al
plasma
concentr
area
concentrationtim
curv
auc
lovastatin
cisaprid
astemizol
also
markedli
increas
grapefruit
juic
bailey
et
al
durat
effect
grapefruit
juic
last
hr
repeat
consumpt
grapejuic
lead
cumul
increas
auc
c
max
coadminist
drug
inhibit
activ
chang
mrna
pglycoprotein
believ
primari
mechan
bailey
et
al
kane
lipski
howev
pharmacokinet
mani
drug
alter
grapefruit
juic
exampl
grapefruit
juic
alter
bioavail
digoxin
diltiazem
amlodipin
human
volunt
indinavir
hivposit
patient
becquemont
et
al
sigusch
et
al
vincent
et
al
although
drug
undergo
presystem
metabol
minor
contributor
find
indic
difficulti
predict
herbdrug
interact
clinic
outcom
herbdrug
interact
depend
factor
relat
coadminist
drug
dose
dose
regimen
administr
rout
pharmacokinet
therapeut
rang
herb
speci
dose
dose
regimen
administr
rout
patient
genet
polymorph
age
gender
patholog
condit
gener
doubl
drug
plasma
concentr
potenti
enhanc
advers
effect
howev
less
mark
chang
may
still
clinic
import
drug
steep
concentrationrespons
relationship
narrow
therapeut
index
chemoprevent
refer
applic
natur
synthet
compound
block
revers
prevent
develop
invas
cancer
shureiqi
et
al
sporn
suh
tamimi
et
al
young
wilson
clinic
evid
indic
feasibl
approach
reduc
risk
major
human
cancer
exampl
tamoxifen
raloxifen
oestrogen
receptor
modul
reduc
risk
develop
breast
cancer
women
increas
risk
fisher
et
al
salih
fentiman
result
aspirin
nonsteroid
antiinflammatori
agent
prove
consist
encourag
epidemiolog
studi
lower
incid
colorect
cancer
jolli
et
al
howev
although
compound
shown
potenti
reduc
cancer
incid
sever
problem
associ
includ
sever
side
effect
due
longterm
use
high
cost
noncompli
therefor
safer
select
chemoprevent
agent
need
number
natur
occur
product
herb
shown
chemoprevent
properti
carcinogenesi
use
vitro
anim
model
chen
et
al
fukutak
et
al
fukutak
et
al
lahirichatterje
et
al
zheng
et
al
mechan
chemoprevent
effect
herbal
prepar
fulli
elucid
inhibit
activ
enzym
enzym
system
protect
effect
toxic
xenobiot
benefici
regul
cell
cycl
cellular
signal
pathway
suggest
wargovich
et
al
natur
occur
isothiocyan
shown
potent
select
inhibitor
carcinogenesi
induc
number
chemic
carcinogen
boysen
et
al
hecht
et
al
yang
et
al
studi
chemoprev
activ
isothiocyan
requir
administr
either
exposur
carcinogen
peitc
inhibit
lung
carcinogenesi
induc
tobaccospecif
nitrosamin
methylnitrosamino
wherea
bitc
ineffect
regard
staretz
hecht
turn
bitc
effect
inhibit
benzo
pyreneinduc
lung
tumor
aj
mice
wherea
peitc
ineffect
lin
et
al
effect
might
relat
inhibitori
mechan
potenc
respect
isothiocyan
peitc
abl
induc
follow
chronic
administr
increas
toxic
smith
et
al
extens
conjug
bitc
gsh
might
also
import
vivo
effect
bitc
conjug
gsh
shown
decreas
potenc
could
contribut
mutagen
raulfheimsoth
baur
appear
local
releas
conjug
product
might
also
contribut
toxic
bitc
hiros
et
al
epidemiolog
studi
suggest
consumpt
fruit
veget
decreas
risk
cancer
develop
block
et
al
combin
bitc
peitc
recent
also
propos
chemoprevent
lung
cancer
individu
resist
smoke
cessat
hecht
kelloff
et
al
effect
appear
mediat
modul
phase
phase
ii
enzym
involv
carcinogen
metabol
isothiocyan
particular
isothiocyanatemedi
inactiv
respons
carcinogen
activ
would
inhibit
carcinogenesi
boysen
et
al
scharf
et
al
zhang
talalay
addit
induct
detoxifi
phase
ii
enzym
may
also
contribut
benefici
effect
isothiocyan
organosulfur
compound
garlic
show
chemoprevent
effect
sever
organ
site
rodent
administr
chemic
carcinogen
perhap
inhibit
carcinogen
activ
reddi
et
al
yang
et
al
compound
also
shown
reduc
incid
multitud
chemic
induc
tumor
anim
model
pretreat
aqueou
garlic
extract
significantli
reduc
frequenc
nmethylnvnitronnitrosoguanidineinduc
micronuclei
chromosom
aberr
arivazhagan
et
al
compound
also
shown
reduc
toxic
induc
thioacetamid
carbon
tetrachlorid
nnitrosodimethylamineand
acetaminophen
substrat
rodent
ramaiah
et
al
wang
et
al
wang
et
al
protect
effect
observ
organosulfur
compound
given
soon
chemic
treatment
diallyl
sulfid
also
shown
induc
cyp
phase
ii
enzym
well
decreas
hepat
catalas
activ
yang
et
al
prevent
effect
garlic
extract
bromobenzeneinduc
hepatotox
precisioncut
liver
slice
relat
elev
hepat
glutathion
content
glutathion
spare
effect
possibl
due
conjug
organosulphur
compound
garlic
extract
toxic
bromobenzen
metabolit
guyonnet
et
al
wang
et
al
organosulfur
compound
also
inhibit
format
dna
adduct
sever
target
tissu
antiprolif
activ
describ
sever
tumor
cell
line
hirsch
et
al
nakagawa
et
al
may
due
induct
apoptosi
alter
cell
cycl
frantz
et
al
kwon
et
al
howev
effect
observ
concentr
much
higher
normal
ingest
human
clinic
trial
need
defin
effect
dose
toxic
human
resveratrol
seem
promis
cancer
chemoprevent
agent
shown
afford
protect
sever
cancer
type
sever
bioassay
system
aziz
et
al
banerje
et
al
li
et
al
mechan
effect
complet
understood
multipl
effect
resveratrol
may
involv
inhibit
phase
enzym
induct
phase
ii
enzym
contribut
chemoprevent
activ
resveratrol
dubuisson
et
al
jang
et
al
also
activ
regul
multipl
cellular
event
associ
carcinogenesi
howev
known
whether
resveratrol
inhibit
catalyt
activ
vivo
potenti
vivo
effect
resveratrol
bioactiv
substrat
may
depend
pharmacokinet
resveratrol
also
tissu
interest
schwedhelm
et
al
known
express
mani
cyp
tissuedepend
omiecinski
et
al
bioactiv
herbal
constitu
appear
critic
step
toxic
induct
herb
result
reactiv
intermedi
bind
coval
dna
protein
lead
organ
toxic
even
carcinogen
hand
herbaldietari
constitu
shown
form
reactiv
intermedi
capabl
irrevers
inhibit
variou
cyp
result
metabolit
lead
cyp
inactiv
chemic
modif
heme
apoprotein
result
coval
bind
modifi
heme
apoprotein
mechanismbas
inhibit
cyp
may
provid
explan
report
herbdrug
interact
natur
occur
compound
inactiv
cyp
may
repres
novel
type
chemoprevent
agent
higher
select
lower
toxic
compar
synthet
compound
herbal
medicin
often
contain
multipl
activ
substanc
multipl
cellular
molecul
might
target
herbal
medicin
identif
target
may
provid
molecular
evid
herb
pharmacolog
activ
toxic
recent
increas
applic
genom
approach
eg
highdens
microarray
analysi
examin
genom
respons
herbal
medicin
afshari
et
al
gohil
gohil
et
al
owuor
kong
watanab
et
al
yang
et
al
approach
identifi
huge
number
eg
gene
repress
stimul
herbal
compound
interest
genom
approach
may
offer
power
tool
defin
predict
pharmacolog
activ
toxic
herbal
medicin
due
wide
use
easi
avail
herbal
medicin
herbal
toxic
becom
issu
concern
safeti
qualiti
herbal
medicin
ensur
greater
research
pharmacovigil
greater
regulatori
control
better
commun
patient
health
profession
hecht
ss
approach
chemoprevent
lung
cancer
base
carcinogen
tobacco
smoke
environment
